Navigation Links
Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
Date:11/1/2009

SAN DIEGO and OSAKA, Japan, Nov. 1, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.

The agreement includes products to be developed from Amylin's pipeline, including pramlintide/metreleptin and davalintide, which are compounds currently in phase 2 development for treatment of obesity. The agreement also includes additional compounds from both companies' obesity research programs. Amylin will receive a one-time up-front payment of $75 million from Takeda and, over the term of the agreement and in relation to the compounds under the agreement, is eligible to receive additional payments upon achieving certain development, commercialization and sales-based milestones that could exceed $1 billion. The agreement also provides for future tiered, double-digit royalty payments to Amylin based on global product sales.

Under the terms of the agreement, Amylin will be responsible for executing development activities for potential products through phase 2 with the aim of regulatory approval in the U.S. Takeda will lead development activities beyond phase 2 in the U.S., and all development activities outside the U.S. In most instances, Amylin will be responsible for 20% of development costs associated with obtaining approval for products in the U.S. and Takeda will be responsible for 80% of such U.S. development costs. Takeda will be responsible for 100% of development costs associated with obtaining approval for products outside the U.S.

Takeda will lead product commercialization, both in the U.S. and outside the U.S., and
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
2. Amylin Pharmaceuticals to Webcast Third Quarter Results
3. Amylin Pharmaceuticals to Webcast Conference Call
4. Amylin Pharmaceuticals to Present at Research & Development Day
5. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
6. Amylin Pharmaceuticals Reports 2007 Financial Results
7. Amylin Pharmaceuticals Reports First Quarter Financial Results
8. Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
9. Lilly and Amylin Set Date and Time for Conference Call
10. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
11. Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... vitamin D begins in the womb, expert says, , , ... mothers who drink lots of milk and have a ... a much lower risk of developing multiple sclerosis later ... 35,794 U.S. nurses whose mothers provided information about their ... for 16 years, and 199 of them developed multiple ...
(Date:2/9/2010)... blood pressure restrict fetal growth, study finds, , , TUESDAY, ... bring into pregnancy can have lasting effects on your ... found that women who smoked, had high blood pressure ... babies that were smaller in the first trimester of ... , "Our study demonstrates that several maternal physical characteristics ...
(Date:2/9/2010)... Insurer-favored ,Cost Solution,: Selling Policies That Amount To ,A ... WASHINGTON , Feb. 9 Blue ... with its premium hikes of up to 39% in ... of questions from the White House and an investigation ... lawmakers should act to regulate health insurance premiums and ...
(Date:2/9/2010)... , Feb. 9 ... J. James Rohack , M.D., President, American ... ,, "The American Medical Association is ... Obama in the Let,s Move Campaign. ... have long worked to address obesity and ...
(Date:2/9/2010)... Institute and the Sanford-Burnham Medical Research Institute have ... owned member of the Roche group, and Roche, ... develop and market human monoclonal antibodies to treat ... viruses include the strains for the current seasonal ... a non-exclusive right to manufacture, develop and market ...
Breaking Medicine News(10 mins):Health News:Drinking Milk While Pregnant May Lower Kids' MS Risk 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 3Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 2Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 3
... of parents will be required by teenagers in Scotland who ... tattoo studios will also be subject to mandatory licensing// to ... to all those who are less than 16 years of ... the possibilities of blood borne diseases being transmitted through contaminated ...
... mother Bernadette Mimura, belonging to Ingleby Barwick Ingleby Barwick who ... disease//. She had refused life-saving treatment as it involved making ... the unborn baby, by the doctors. ,Being a ... a mild form of chemotherapy treatment with the object of ...
... to feel happy about the way he looks by just looking ... looks great he is convinced//. ,Women on the other ... difficult to satisfy them unless they are supplemented with actual results. ... was conducted by Kathleen Martin Ginis, associate professor of kinesiology at ...
... that moderate exercise has positive benefits on the hearts, ... studies in the last 10 to 20 years have ... people suffering from congestive heart failure. ,However, the ... to be statistically significant. ,In the new study ...
... on the Gulf of Carpentaria in Australia has triggered concerns ... virus//. ,However, the Australian Quarantine and Inspection Service ... they were sending out a team as a precautionary measure, ... a military operative has also started towards the island. "There's ...
... has been found to be effective in treatment of ... benefited from vitamin treatment as found by researchers from ... intervention wherein patients not responsive to steroid treatment after ... ,Professor Tak Lee, Director of the MRC-Asthma UK ...
Other Medicine News:Health News:Asthma an be treated with Vitamin supplement intervention 2
(Date:2/9/2010)... , Feb. 9 LIVESTRONG ... and print-on-demand publication from LIVE STRONG .  The magazine ... against cancer; resources and information about cancer prevention and ... ,, "As a three-time cancer survivor, I understand ... personal level," said LIVE STRONG President and CEO ...
(Date:2/9/2010)... Volcano Corporation (Nasdaq: VOLC ... intravascular therapy guidance tools designed to enhance the ... disease, announced today that it has acquired the ... Biomedical. Volcano became the exclusive global distributor of ... This acquisition reinforces Volcano,s dedication to build a ...
(Date:2/9/2010)... 9 Glycemion Strategies, Inc., an ... for diabetic consumers and their professional healthcare providers, ... Program to benefit the 30,000 US Diabetes Educators ... they serve. ,, The Portrait Health™ ... to provide real-time access to health information, especially ...
Breaking Medicine Technology:SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 2SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 3SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 4Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 2Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 3Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 4Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 5Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 2Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 3Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells 49774 1Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells 49774 2Ontario women live longer but dont prosper 3A Study 49770 1Ontario women live longer but dont prosper 3A Study 49770 2Ontario women live longer but dont prosper 3A Study 49770 3Ontario women live longer but dont prosper 3A Study 49770 4Energy saving method checks refrigerant level in air conditioners 8970 1Energy saving method checks refrigerant level in air conditioners 8970 2
... BOSTON, Oct. 6 "A return to the ... is without scientific,justification," according to a paper released ... "An Assessment of the Role of,Chimpanzees in AIDS ... not predictive of responses in humans, and that ...
... Collaborate to Improve Patient Safety, WASHINGTON, ... in collaboration with the American College of ... consensus guidelines,outlining a stepwise approach for reducing ... among patients using nonsteroidal,anti-inflammatory drugs (NSAIDs) along ...
Other Medicine Technology:Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4
... Every Bard® Biopsy Instrument and Needle ... one important goal: a large quality, reliable ... exceptional performance, featuring ultra-sharp tips and polished ... broad selection of biopsy systems and needle ...
... Needle is specially designed to help you ... reliable core sample. All needles are engineered ... polished surfaces for smooth entry and exit. ... needle sizes assures an ideal match with ...
... designed to bring efficiency and quality to ... the superior technology of fluorescent flow cytometry ... Continuous sampling or batch processing are easily ... processing in high volume laboratories. Fluorescent ...
... Cartridge System is a single-use, disposable needle ... spacers into a Bard BrachyStar needle for ... outer radiation safety shield, inner compartment that ... molded fitting that connects the cartridge to ...
Medicine Products: